Eficacia de bosentán en el tratamiento de las úlceras digitales de la tromboangitis obliterante

Prior, Águeda; Rodriguez-Muguruza, Samantha; Sanint, Juana; Olivé, Alejandro.
Med. clín (Ed. impr.) ; 145(1): 44-44, jul. 2015.
Artículo en Español | IBECS (España) | ID: ibc-138562

Documentos relacionados

  1. Thromboangiitis Obliterans　- A Disappearing Disease?
  2. Therapeutic Angiogenesis for Thromboangiitis Obliterans.
  3. [Comprehensive treatment of a patient with Buerger's disease using genetically engineered complexes VEGF-165].
  4. Top 100 cited articles in the thromboangiitis obliterans: a bibliometric analysis and visualized study.
  5. [Thromboangiitis obliterans: notions for practice].
  6. Integrated pharmacokinetics and pharmacometabolomics to reveal the synergistic mechanism of a multicomponent Chinese patent medicine, Mailuo Shutong pills against thromboangiitis obliterans.
  7. The Effect of Smoking Cessation on the Technical Success of Endovascular Treatment for Thromboangiitis Obliterans.
  8. Milestones in thromboangiitis obliterans: a position paper of the VAS-European independent foundation in angiology/vascular medicine.
  9. Thromboangiitis obliterans (Buerger's disease).
  10. Thromboangiitis Obliterans (Buerger's Disease) in an Adolescent Male.